4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Alterity Therapeutics Limited (ATHE) operates in the Biotechnology industry and is headquartered in Melbourne, Australia with about 11 employees. Its market capitalization is roughly $83 million. In the fiscal year ended 2026-06-30, ATHE reported AUD 0M in revenue and (AUD 23M) in net income.
Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease.
Interactive charts & full statements → Open the ATHE valuation workbench →
| Income statement | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Revenue | AUD 0M | AUD 0M | AUD 0M | AUD 0M | — |
| Operating Income (EBIT) | (AUD 25M) | (AUD 12M) | (AUD 20M) | (AUD 15M) | — |
| Net Income | (AUD 23M) | (AUD 12M) | (AUD 19M) | (AUD 14M) | — |
AUD; AUDM / AUDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | — | AUD 0M | AUD 0M | — | AUD 0M | AUD 0M |
AUD; AUDM / AUDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Assets | AUD 46M | AUD 46M | AUD 19M | AUD 27M | — |
| Total Liabilities | AUD 3M | AUD 4M | AUD 5M | AUD 4M | — |
AUD; AUDM / AUDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ATHE viewer.
About TickerBase · Data methodology & sources · Privacy · Terms